Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
FTSE 350 News
-
FTSE 350
Information -
FTSE 350
Constituents -
FTSE 350
News -
FTSE 350
Charts -
FTSE 350
RNS -
FTSE 350
Chat -
FTSE 350
Risers -
FTSE 350
Fallers
FTSE 350
FTSE 350 (NMX) Index Information
Last checked at -
Last checked at 
LONDON MARKET OPEN: FTSE 100 down as GSK buys US drugmaker Nuvalent
(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 fell after GSK agreed to buy US-based cancer drug developer Nuvalent...
Glaxosmithkline
UPDATE: GSK buys cancer drug developer Nuvalent for USD10.6 billion
(Alliance News) - GSK PLC on Tuesday said it has agreed to US-based cancer drug developer Nuvalent Inc for USD10.6 billion.
Oxford Instruments shares fall despite results ahead of expectations
(Sharecast News) - Oxford Instruments shares fell more than 6% on Tuesday morning despite the company reporting full-year results slightly ahead of ex...
Oxford Instruments
FRC to probe PwC's 2024 audit of WHSmith
(Sharecast News) - The Financial Reporting Council opened an investigation into PwC's audit of WH Smith's accounts for the year ended 31 August 2024 o...
Wh Smith
Bellway sticks with annual outlook but demand cools in April and May
(Alliance News) - Bellway PLC on Tuesday backed full-year profit guidance but noted the outlook beyond the current financial year remains uncertain, w...
Bellway
IN BRIEF: Relx launches GBP200 million share buyback programme
Relx PLC - London-based provider of business, scientific and legal information - Commences a new share buyback scheme worth GBP200 million, and runs u...
Relx
Keller secures $207m variation to I-40 contract
(Sharecast News) - Geotechnical contractor Keller said on Tuesday that it has been awarded a contract variation order in relation to the reconstructio...
Keller
AstraZeneca progresses elecoglipron after positive phase IIb results
(Alliance News) - AstraZeneca PLC on Monday announced positive results from the Vista and Solstice phase IIb trials of elecoglipron, an oral small mol...
Astrazeneca
LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...
WPP
GSK to buy Boston-based biopharmaceutical firm Nuvalent for $10.6bn
(Sharecast News) - GSK said on Tuesday that it has agreed to buy Boston-based oncology-focused biopharmaceutical firm Nuvalent for $10.6bn (£7.9b...
Bellway sees softer demand, rising building costs
(Sharecast News) - UK housebuilder Bellway held guidance but said customer demand had moderated in recent weeks after a positive start to the spring s...
Exane BNPP upgrades Bunzl to 'outperform'
(Sharecast News) - Exane BNP Paribas upgraded Bunzl to 'outperform' from 'neutral' on Tuesday and hiked the price target to 3,000p from 2,450p as it s...
Bunzl
Molten Ventures reports sharp rise in profit, ICEYE valuation uplift
(Sharecast News) - Molten Ventures reported a sharp rise in annual profit and net asset value on Tuesday, alongside a further valuation uplift from po...
Molten Ventures
LONDON MARKET EARLY CALL: FTSE 100 to rise as Israel, Iran end attacks
(Alliance News) - Stocks in London are set to open slightly higher on Tuesday, after Iran and Israel said they would end recent hostilities that had t...
World's biggest banks increased fossil fuel financing by 8% in 2025
(Alliance News) - The world's biggest banks together increased their fossil fuel financing by 8% in 2025, an analysis has found.
Barclays
Follow the stocks
